Minnesota Congressman Erik Paulsen projects a bill repealing the medical device tax will be passed – soon. “I think we’re going to see that get across the finish line at some point this year,” he said, speaking at this week’s MedTech Investor Conference in Minneapolis. Paulsen said a Ways and Means committee has been scheduled for June 2 to figure […]
Medical device industry professionals have been asked to remember and apply that aphorism their grandmothers said about a little thank you going a long way in the campaign to kill the device tax. Though the Senate voted to repeal the medical device excise tax more than four months ago, last week, Joe Hage, the leader […]
Rep. Erik Paulsen (R-Minn.) appears to be gaining ground in ginning up support for his resurrected “Defend Medical Innovation Act,” which seeks to block the 2.3 percent tax on medical device company revenues prescribed by President Barack Obama’s health care overhaul last year. Paulsen’s “Dear Colleague” letter urging legislators to repeal the tax which, “unfairly […]
U.S. Rep. Erik Paulsen, one of the top boosters for the medical device industry in Congress, doesn’t see a major repeal of health reform taking place. Still, the Minnesota Republican is hopeful some aspects of the law will change, including an upcoming tax on medical devices that Paulsen believes will stifle innovation. The nearly 50-member […]
Opponents of the medical device tax have filed three bills in an attempt to defeat the measure, which would tax the makers of new innovative medical devices $20 billion over 10 years. "A $20 billion tax hike on medical device manufacturers to fund Obamacare will cripple an important engine of opportunity, job growth and innovation, while hurting the advancement of technologies essential to improving patient care," Republican Sen. Orrin Hatch state.
Fresh off his vote to repeal healthcare reform, Minnesota Congressman Erik Paulsen is circulating a "Dear Colleague" letter hoping to gather sponsors and resurrect his bill to repeal the medical device tax (called the Defend Medical Innovation Act).
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Minnesota Sens. Amy Klobuchar and Al Franken along with Rep. Erik Paulsen have championed the medical device industry, giving speech after speech and writing letter after letter to the Food and Drug Administration about upcoming changes to its 510(k) approval program. I doubted the campaign would do much. But Wednesday, a bipartisan group of 15 senators sent a letter to FDA Commissioner Dr. Margaret Hamburg urging her agency, among other things, to adopt a more deliberate, cautious approach to amending 510(k).
Minnesota’s medical device community has enlisted some big guns to lobby the Food and Drug Administration against proposed changes that the industry says will hurt innovation and the state’s economy: United States Sen. Amy Klobuchar and Congressman Erik Paulsen. In a letter to FDA Commissioner Dr. Margaret Hamburg, Klobuchar, chair of the Senate Commerce Subcommittee […]
